Changes in Brain Structure, Function, and Network Properties in Patients With First-Episode Schizophrenia Treated With Antipsychotics

Código QR

Changes in Brain Structure, Function, and Network Properties in Patients With First-Episode Schizophrenia Treated With Antipsychotics

Purpose: Comprehensive and longitudinal brain analysis is of great significance for understanding the pathological changes of antipsychotic drug treatment in patients with schizophrenia. This study aimed to investigate the changes of structure, function, and network properties in patients with first...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Ping Yin, Chao Zhao, Yang Li, Xiaoyi Liu, Lei Chen, Nan Hong
Formato:	article
Lenguaje:	EN
Publicado:	Frontiers Media S.A. 2021
Materias:	schizophrenia first-episode antipsychotics neuroimaging functional magnetic resonance imaging Psychiatry RC435-571
Acceso en línea:	https://doaj.org/article/daae0975f468420da57a6fadca6f1e10
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Altered Peripheral Immune Profiles in First-Episode, Drug-Free Patients With Schizophrenia: Response to Antipsychotic Medications
por: Lei Chen, et al.
Publicado: (2021)

Gender Differences in the First-Year Antipsychotic Treatment for Chinese First-Episode Schizophrenia
por: Pu C, et al.
Publicado: (2020)

Duration Mismatch Negativity Predicts Remission in First-Episode Schizophrenia Patients
por: Suguru Nakajima, et al.
Publicado: (2021)

The Implementation and Review of Cognitive Remediation Training for First Episode Psychosis in Singapore
por: Nigel Ian Ming Chong, et al.
Publicado: (2021)

Long-term outcomes of antipsychotic treatment in patients with first-episode schizophrenia: a systematic review
por: Karson C, et al.
Publicado: (2016)

Aberrant Learned Irrelevance in Patients with First-Episode Schizophrenia-Spectrum Disorder
por: Ryan Sai-Ting Chu, et al.
Publicado: (2021)

The More, the Merrier…? Antipsychotic Polypharmacy Treatment Strategies in Schizophrenia From a Pharmacology Perspective
por: Stephan Hjorth, et al.
Publicado: (2021)

Clinical Validity of Subjective Clinical Prognosis in First Episode Psychosis Schizophrenia Patients: An Analysis of Data from the European First Episode Schizophrenia Trial (EUFEST) Study
por: Matei VP, et al.
Publicado: (2020)

Investigaciones en rehabilitación cognitiva para pacientes con esquizofrenia (2004-2013): una revisión temática en beneficio de propuestas para etapas iniciales del trastorno
por: Loubat O,Margarita, et al.
Publicado: (2014)

Metabolic disturbances in patients with paranoid schizophrenia treated with atypical antipsychotic drugs
por: Leonid Mikhaylovich Bardenshteyn, et al.
Publicado: (2010)

Characterization of antipsychotic medications, amino acid signatures, and platelet-activating factor in first-episode psychosis
por: Bracha Erlanger Avigdor, et al.
Publicado: (2021)

Cortical Pathways or Mechanism in the Face Inversion Effect in Patients with First-Episode Schizophrenia
por: Liu Y, et al.
Publicado: (2021)

Stimuli may have little impact on the deficit of visual working memory accuracy in first-episode schizophrenia
por: She S, et al.
Publicado: (2019)

Proton magnetic resonance spectroscopy changes in a longitudinal schizophrenia study: a pilot study in eleven patients
por: Galińska-Skok B, et al.
Publicado: (2019)

Clinical Features of First-episode Psychoses During the COVID-19 Pandemic
por: Vladimir A. Zyablov, et al.
Publicado: (2021)

The Relationship between the Second-Generation Antipsychotics Efficacy and the Traditional Chinese Medicine Body Constitutions in Patients with Schizophrenia
por: Tzu-Pei Yeh, et al.
Publicado: (2021)

Temporal Dynamics in Degree Centrality of Brain Functional Connectome in First-Episode Schizophrenia with Different Short-Term Treatment Responses: A Longitudinal Study
por: Wang Y, et al.
Publicado: (2021)

Taiwan Expert Consensus Recommendations for Switching to Aripiprazole Long-Acting Once-Monthly in Patients with Schizophrenia
por: Chih-Sung Liang, et al.
Publicado: (2021)

Verbal memory improvement in first-episode psychosis APOE-ε4 carriers: a pleiotropic effect?
por: Vila-Rodriguez F, et al.
Publicado: (2017)

Antipsychotics and risk of natural death in patients with schizophrenia
por: Chen Y, et al.
Publicado: (2019)

Case Report: Cariprazine Efficacy in Young Patients Diagnosed With Schizophrenia With Predominantly Negative Symptoms
por: Octavian Vasiliu
Publicado: (2021)

Association between IL-6 and metabolic syndrome in schizophrenia patients treated with second-generation antipsychotics
por: Fang X, et al.
Publicado: (2019)

Second-generation long-acting injectable antipsychotics in schizophrenia: patient functioning and quality of life
por: Montemagni C, et al.
Publicado: (2016)

A systematic review of the effects of psychiatric medications on social cognition
por: Zoë Haime, et al.
Publicado: (2021)

Diagnosis and Treatment of Depression in Patients with Schizophrenia
por: Sergey N. Mosolov
Publicado: (2020)

Lateralized Contributions of Medial Prefrontal Cortex Network to Episodic Memory Deficits in Subjects With Amnestic Mild Cognitive Impairment
por: Qing Ye, et al.
Publicado: (2021)

Magnetic resonance imaging
Publicado: (1982)

Association Analysis Between Catechol-O-Methyltransferase Expression and Cognitive Function in Patients with Schizophrenia, Bipolar Disorder, or Major Depression
por: Ni P, et al.
Publicado: (2021)

Transfer Learning for Alzheimer’s Disease through Neuroimaging Biomarkers: A Systematic Review
por: Deevyankar Agarwal, et al.
Publicado: (2021)

Targets, attitudes, and goals of psychiatrists treating patients with schizophrenia: key outcome drivers, role of quality of life, and place of long-acting antipsychotics
por: de Bartolomeis A, et al.
Publicado: (2016)

Magnetic resonance insights

A Multimodal Fusion Analysis of Pretreatment Anatomical and Functional Cortical Abnormalities in Responsive and Non-responsive Schizophrenia
por: Chenyang Yao, et al.
Publicado: (2021)

Relationship between TNF-α levels and psychiatric symptoms in first-episode drug-naïve patients with schizophrenia before and after risperidone treatment and in chronic patients
por: Chen Lin, et al.
Publicado: (2021)

Inflammatory Response in SARS-CoV-2 Infection of Patients with Schizophrenia and Long-Term Antipsychotic Treatment
por: Moga S, et al.
Publicado: (2021)

Attitudes toward long-acting injectable antipsychotics among patients with schizophrenia in Japan
por: Sugawara N, et al.
Publicado: (2019)

Cannabidiol Cigarettes as Adjunctive Treatment for Psychotic Disorders – A Randomized, Open-Label Pilot-Study
por: Patrick Köck, et al.
Publicado: (2021)

Journal of cardiovascular magnetic resonance official journal of the Society for Cardiovascular Magnetic Resonance.
Publicado: (1998)

Immunoinflammatory Profile in Patients with Episodic and Continuous Paranoid Schizophrenia
por: Irina K. Malashenkova, et al.
Publicado: (2021)

Automatic Diagnosis of Schizophrenia in EEG Signals Using CNN-LSTM Models
por: Afshin Shoeibi, et al.
Publicado: (2021)

Cariprazine: Patients with Treatment-Resistant Schizophrenia
por: Aubel T
Publicado: (2021)